Veterinary Combination Vaccine and Multivalent Vaccine Industry Research Report 2025

Summary

According to APO Research, the global Veterinary Combination Vaccine and Multivalent Vaccine market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Veterinary Combination Vaccine and Multivalent Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Veterinary Combination Vaccine and Multivalent Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Veterinary Combination Vaccine and Multivalent Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Veterinary Combination Vaccine and Multivalent Vaccine include Bioveta, Boehringer Ingelheim, Ceva Animal Health, Elanco, HIPRA, Merck Animal Health, Virbac, Zoetis and Aichong Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Combination Vaccine and Multivalent Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Combination Vaccine and Multivalent Vaccine.

The report will help the Veterinary Combination Vaccine and Multivalent Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Veterinary Combination Vaccine and Multivalent Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Combination Vaccine and Multivalent Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Veterinary Combination Vaccine and Multivalent Vaccine Segment by Company

Bioveta
Boehringer Ingelheim
Ceva Animal Health
Elanco
HIPRA
Merck Animal Health
Virbac
Zoetis
Aichong Group
Bolaideli Biotechnology
Harbin Pharmaceutical Group
Huapai Biotechnology
Keqian Biology
Pulike Biological
Ringpu Bio-technology
Yian Biological
China Animal Husbandy Industry
Veterinary Combination Vaccine and Multivalent Vaccine Segment by Type

Combination Vaccine
Multivalent Vaccine
Veterinary Combination Vaccine and Multivalent Vaccine Segment by Application

Domestic Animal
Poultry
Veterinary Combination Vaccine and Multivalent Vaccine Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Combination Vaccine and Multivalent Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Combination Vaccine and Multivalent Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Combination Vaccine and Multivalent Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Combination Vaccine and Multivalent Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Combination Vaccine and Multivalent Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Combination Vaccine and Multivalent Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Market Size (2020-2031)
2.2.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales (2020-2031)
2.2.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Market Average Price (2020-2031)
2.3 Veterinary Combination Vaccine and Multivalent Vaccine by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Combination Vaccine
2.3.3 Multivalent Vaccine
2.4 Veterinary Combination Vaccine and Multivalent Vaccine by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Domestic Animal
2.4.3 Poultry
3 Market Competitive Landscape by Manufacturers
3.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units) of Manufacturers (2020-2025)
3.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue of Manufacturers (2020-2025)
3.4 Global Veterinary Combination Vaccine and Multivalent Vaccine Average Price by Manufacturers (2020-2025)
3.5 Global Veterinary Combination Vaccine and Multivalent Vaccine Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Veterinary Combination Vaccine and Multivalent Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Veterinary Combination Vaccine and Multivalent Vaccine, Product Type & Application
3.8 Global Manufacturers of Veterinary Combination Vaccine and Multivalent Vaccine, Established Date
3.9 Global Veterinary Combination Vaccine and Multivalent Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Bioveta
4.1.1 Bioveta Company Information
4.1.2 Bioveta Business Overview
4.1.3 Bioveta Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Bioveta Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.1.5 Bioveta Recent Developments
4.2 Boehringer Ingelheim
4.2.1 Boehringer Ingelheim Company Information
4.2.2 Boehringer Ingelheim Business Overview
4.2.3 Boehringer Ingelheim Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Boehringer Ingelheim Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.2.5 Boehringer Ingelheim Recent Developments
4.3 Ceva Animal Health
4.3.1 Ceva Animal Health Company Information
4.3.2 Ceva Animal Health Business Overview
4.3.3 Ceva Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Ceva Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.3.5 Ceva Animal Health Recent Developments
4.4 Elanco
4.4.1 Elanco Company Information
4.4.2 Elanco Business Overview
4.4.3 Elanco Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Elanco Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.4.5 Elanco Recent Developments
4.5 HIPRA
4.5.1 HIPRA Company Information
4.5.2 HIPRA Business Overview
4.5.3 HIPRA Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.5.4 HIPRA Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.5.5 HIPRA Recent Developments
4.6 Merck Animal Health
4.6.1 Merck Animal Health Company Information
4.6.2 Merck Animal Health Business Overview
4.6.3 Merck Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Merck Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.6.5 Merck Animal Health Recent Developments
4.7 Virbac
4.7.1 Virbac Company Information
4.7.2 Virbac Business Overview
4.7.3 Virbac Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Virbac Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.7.5 Virbac Recent Developments
4.8 Zoetis
4.8.1 Zoetis Company Information
4.8.2 Zoetis Business Overview
4.8.3 Zoetis Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Zoetis Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.8.5 Zoetis Recent Developments
4.9 Aichong Group
4.9.1 Aichong Group Company Information
4.9.2 Aichong Group Business Overview
4.9.3 Aichong Group Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Aichong Group Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.9.5 Aichong Group Recent Developments
4.10 Bolaideli Biotechnology
4.10.1 Bolaideli Biotechnology Company Information
4.10.2 Bolaideli Biotechnology Business Overview
4.10.3 Bolaideli Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Bolaideli Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.10.5 Bolaideli Biotechnology Recent Developments
4.11 Harbin Pharmaceutical Group
4.11.1 Harbin Pharmaceutical Group Company Information
4.11.2 Harbin Pharmaceutical Group Business Overview
4.11.3 Harbin Pharmaceutical Group Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Harbin Pharmaceutical Group Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.11.5 Harbin Pharmaceutical Group Recent Developments
4.12 Huapai Biotechnology
4.12.1 Huapai Biotechnology Company Information
4.12.2 Huapai Biotechnology Business Overview
4.12.3 Huapai Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Huapai Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.12.5 Huapai Biotechnology Recent Developments
4.13 Keqian Biology
4.13.1 Keqian Biology Company Information
4.13.2 Keqian Biology Business Overview
4.13.3 Keqian Biology Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Keqian Biology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.13.5 Keqian Biology Recent Developments
4.14 Pulike Biological
4.14.1 Pulike Biological Company Information
4.14.2 Pulike Biological Business Overview
4.14.3 Pulike Biological Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Pulike Biological Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.14.5 Pulike Biological Recent Developments
4.15 Ringpu Bio-technology
4.15.1 Ringpu Bio-technology Company Information
4.15.2 Ringpu Bio-technology Business Overview
4.15.3 Ringpu Bio-technology Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.15.4 Ringpu Bio-technology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.15.5 Ringpu Bio-technology Recent Developments
4.16 Yian Biological
4.16.1 Yian Biological Company Information
4.16.2 Yian Biological Business Overview
4.16.3 Yian Biological Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Yian Biological Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.16.5 Yian Biological Recent Developments
4.17 China Animal Husbandy Industry
4.17.1 China Animal Husbandy Industry Company Information
4.17.2 China Animal Husbandy Industry Business Overview
4.17.3 China Animal Husbandy Industry Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.17.4 China Animal Husbandy Industry Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
4.17.5 China Animal Husbandy Industry Recent Developments
5 Global Veterinary Combination Vaccine and Multivalent Vaccine Market Scenario by Region
5.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region: 2020-2031
5.2.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region: 2020-2025
5.2.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region: 2026-2031
5.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Region: 2020-2031
5.3.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Region: 2020-2025
5.3.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Region: 2026-2031
5.4 North America Veterinary Combination Vaccine and Multivalent Vaccine Market Facts & Figures by Country
5.4.1 North America Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2020-2031)
5.4.3 North America Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Veterinary Combination Vaccine and Multivalent Vaccine Market Facts & Figures by Country
5.5.1 Europe Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2020-2031)
5.5.3 Europe Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Veterinary Combination Vaccine and Multivalent Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2020-2031)
5.6.3 Asia Pacific Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Veterinary Combination Vaccine and Multivalent Vaccine Market Facts & Figures by Country
5.7.1 South America Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2020-2031)
5.7.3 South America Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Veterinary Combination Vaccine and Multivalent Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2020-2031)
5.8.3 Middle East and Africa Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2020-2031)
6.1.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2020-2031) & (Units)
6.1.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Type (2020-2031)
6.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2020-2031)
6.2.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Type (2020-2031)
6.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Price by Type (2020-2031)
7 Segment by Application
7.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2020-2031)
7.1.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2020-2031) & (Units)
7.1.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Application (2020-2031)
7.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2020-2031)
7.2.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Application (2020-2031)
7.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Veterinary Combination Vaccine and Multivalent Vaccine Value Chain Analysis
8.1.1 Veterinary Combination Vaccine and Multivalent Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Veterinary Combination Vaccine and Multivalent Vaccine Production Mode & Process
8.2 Veterinary Combination Vaccine and Multivalent Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Veterinary Combination Vaccine and Multivalent Vaccine Distributors
8.2.3 Veterinary Combination Vaccine and Multivalent Vaccine Customers
9 Global Veterinary Combination Vaccine and Multivalent Vaccine Analyzing Market Dynamics
9.1 Veterinary Combination Vaccine and Multivalent Vaccine Industry Trends
9.2 Veterinary Combination Vaccine and Multivalent Vaccine Industry Drivers
9.3 Veterinary Combination Vaccine and Multivalent Vaccine Industry Opportunities and Challenges
9.4 Veterinary Combination Vaccine and Multivalent Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings